SEC Form 4 · accession 0001225208-16-043720
Nobilis Health Corp. · HLTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry Joseph Fleming
Officer — Chief Executive Officer · Director
Period of report
Dec 21, 2016
Accepted (ET)
Dec 27, 2016 · 8:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001409916
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $1.92 | Dec 21, 2016 | A | 150,000 | A | Mar 31, 2016 | Dec 21, 2026 | Common | 150,000 | 150,000 | D |
Explanation of responses
- F1Stock Options granted at C$2.57 calculated on a 5-day volume weighted average price (VWAP) for 5 business days - 12/15/16 through 12/21/2016.
- F2Vest ratably on a calendar quarter basis beginning on 3/31/17 until final vesting date of 12/31/19.